Article
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2015
Johnatty Sharon E, Tyrer Jonathan P, Kar Siddhartha, Beesley Jonathan, Lu Yi, Gao Bo, Fasching Peter A, Hein Alexander, Ekici Arif B, Beckmann Matthias W, Lambrechts Diether, Van Nieuwenhuysen Els, Vergote Ignace, Lambrechts Sandrina, Rossing Mary Anne, Doherty Jennifer A, Chang-Claude Jenny, Modugno Francesmary, Ness Roberta B, Moysich Kirsten B, Levine Douglas A, Kiemeney Lambertus A, Massuger Leon F A G, Gronwald Jacek, Lubiński Jan, Jakubowska Anna, Cybulski Cezary, Brinton Louise, Lissowska Jolanta, Wentzensen Nicolas, Song Honglin, Rhenius Valerie, Campbell Ian, Eccles Diana, Sieh Weiva, Whittemore Alice S, McGuire Valerie, Rothstein Joseph H, Sutphen Rebecca, Anton-Culver Hoda, Ziogas Argyrios, Gayther Simon A, Gentry-Maharaj Aleksandra, Menon Usha, Ramus Susan J, Pearce Celeste L, Pike Malcolm C, Stram Daniel O, Wu Anna H, Kupryjanczyk Jolanta, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Spiewankiewicz Beata, Goodman Marc T, Wilkens Lynne R, Carney Michael E, Thompson Pamela J, Heitz Florian, du Bois Andreas, Schwaab Ira, Harter Philipp, Pisterer Jacobus, Hillemanns Peter, Karlan Beth Y, Walsh Christine, Lester Jenny, Orsulic Sandra, Winham Stacey J, Earp Madalene, Larson Melissa C, Fogarty Zachary C, Høgdall Estrid, Jensen Allan, Kjaer Susanne Kruger, Fridley Brooke L, Cunningham Julie M, Vierkant Robert A, Schildkraut Joellen M, Iversen Edwin S, Terry Kathryn L, Cramer Daniel W, Bandera Elisa V, Orlow Irene, Pejovic Tanja, Bean Yukie, Høgdall Claus, Lundvall Lene, McNeish Ian, Paul James, Carty Karen, Siddiqui Nadeem, Glasspool Rosalind, Sellers Thomas, Kennedy Catherine, Chiew Yoke-Eng, Berchuck Andrew, MacGregor Stuart, Pharoah Paul D P, Goode Ellen L, deFazio Anna, Webb Penelope M, Chenevix-Trench Georgia
Abstract excerpt
PURPOSE: Chemotherapy resistance remains a major challenge in the treatment of ovarian cancer. We hypothesize that germline polymorphisms might be associated with clinical outcome. EXPERIMENTAL DESIGN: We analyzed approximately 2.8 million genotyped and imputed SNPs from the iCOGS experiment for progression-free survival (PFS) and overall survival (OS) in 2,901 European epithelial ovarian cancer (EOC) patients...
